Page last updated: 2024-08-25

carbohydrazide and Muscular Dystrophy, Duchenne

carbohydrazide has been researched along with Muscular Dystrophy, Duchenne in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bazan, NA; Chatzopoulou, M; Conole, D; Davies, KE; Davies, SG; Donald, JR; Edwards, B; Fairclough, RJ; Martínez, RF; Milner, JA; Russell, AJ; Shah, N; Squire, SE; Vuorinen, A; Wilkinson, IVL; Willis, NJ; Wilson, FX; Wynne, GM1

Other Studies

1 other study(ies) available for carbohydrazide and Muscular Dystrophy, Duchenne

ArticleYear
Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy.
    European journal of medicinal chemistry, 2021, Aug-05, Volume: 220

    Topics: Dose-Response Relationship, Drug; Drug Discovery; Humans; Hydrazines; Molecular Structure; Muscular Dystrophy, Duchenne; Pyrimidines; RNA, Messenger; Structure-Activity Relationship; Utrophin

2021